Organon & Co (OGN) Earnings Date & Reports

Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

OGN is expected to report earnings to 90 cents per share on May 01

Q1'25

Est.

$0.91

Q4'24

Missed

by $0.01

Q3'24

Missed

by $0.03

Q2'24

Beat

by $0.04

Q1'24

Beat

by $0.24

The last earnings report on February 13 showed earnings per share of 89 cents, missing the estimate of 91 cents. With 797.29K shares outstanding, the current market capitalization sits at 4.73B.

View a ticker or compare two or three

Compare

OGN